Recently, it has also been elucidated that in experimental rat models exposed to 6-OHDA, NPY treatment culminated in the suppression of microglia in two regions, i.e., striatal and SN, which, as a consequence, facilitated the anti-inflammatory action of NPY in the PD [170]. The gene discussed is NPY; the disease is Parkinson disease.